U.S Surgical Instruments Market to reach $12.1 Billion by 2031; Rising surgical procedures, increased preference for minimally invasive surgeries, growing healthcare expenditure, technological advancements, emphasis on reducing healthcare costs are d

The U.S Surgical Instruments Market size is estimated to reach $12.1 Billion by 2031, growing at a CAGR of 8.1% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “U.S Surgical Instruments Market– By Instrument Type (Handheld Instruments, Electrosurgical Instruments, Surgical Scopes, Laparoscopic Instruments, Cutting Instruments, Surgical Sutures and Staples, Others), By Type of Surgery (Open Surgery, Minimal Invasive Surgery), By Application (Cardiology, Obstetrics and Gynecology, Gastroenterology, Urology, Neurology, Plastic & Reconstructive Surgery, Orthopedics, Ophthalmology, Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) Opportunity Analysis & Industry Forecast, 2025-2031.”

Rising surgical procedures are increasing the demand for advanced instruments. The preference for minimally invasive surgeries drives the need for specialized tools. Growing healthcare expenditure supports the adoption of innovative surgical devices. Technological advancements enhance the precision and efficiency of instruments. The focus on reducing healthcare costs encourages the use of cost-effective and durable tools.

Cardiology is the largest segment in the U.S. Surgical Instruments Market by application, driven by the high volume of cardiac procedures performed annually. According to Baystate Health, coronary artery bypass grafting (CABG), commonly known as heart bypass surgery, is the most frequently performed major surgical procedure in the U.S., with approximately 400,000 surgeries conducted each year. Data from the Annals of Thoracic Surgery Short Reports further underscores the dominance of cardiac surgeries in the U.S., which leads globally in surgical volumes. The U.S. records an average cardiac surgical volume of 271.5 per 100,000 population annually, the highest among 24 countries analyzed. For CABG alone, the U.S. achieves an average of 64.5 procedures per 100,000 population each year, significantly outpacing other nations. These numbers highlight the critical role of cardiology in driving demand for surgical instruments, as advancements in technology and the prevalence of cardiovascular diseases sustain the high volume of cardiac surgeries in the country.

The U.S. surgical instruments market is driven by the rising prevalence of chronic diseases, in particular obesity. The World Obesity Federation states obesity rates will rise globally, and that the number of adults living with obesity is forecast to increase from 0.81 billion in 2020 to 1.53 billion in 2035. The surge also emphasizes the increasing need for bariatric surgery, a procedure that helps people with extreme obesity to lose weight. Bariatric surgeries, such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding, limit the stomach’s capacity, reduce nutrient absorption or both. The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) reported more than 480,000 procedures in 24 countries, expanding the need for high technology surgical instruments to treat these conditions.

The rising number of surgical procedures is a significant driver in the U.S. Surgical Instruments Market, with cancer-related surgeries being a major contributor. According to the American Cancer Society Journals, the United States saw approximately 2,001,140 new cancer cases in 2024, averaging around 5,480 diagnoses daily. Additionally, cancer remains the second leading cause of death in the U.S., accounting for about 611,720 deaths in 2024, or roughly 1,680 per day. These statistics highlight the growing burden of cancer, which often necessitates surgical interventions for diagnosis, treatment, or palliation. As cancer remains a leading health concern, the demand for advanced surgical instruments continues to grow, enabling precise and effective procedures. Furthermore, the increasing prevalence of other conditions requiring surgical treatment contributes to the rising volume of surgeries. This trend underscores the critical role of surgical instruments in addressing the nation’s healthcare needs, driving advancements and investments in this market.

Key companies profiled in the U.S Surgical Instruments Market are Medtronic, Boston Scientific Corporation, Johnson & Johnson, CONMED Corporation, Smith & Nephew, B. Braun Group, Olympus Medical, Cardinal Health, Stryker Corporation, Intuitive Surgical and others.

Surgical Sutures Market– Surgical Sutures Market size is estimated to reach $7.5 billion by 2030, growing at a CAGR of 3.7% during the forecast period 2024-2030. Key drivers include the rising prevalence of chronic diseases like cancer, blood disorders, and autoimmune conditions, along with a growing geriatric population. Technological advancements in suture materials and an increase in surgical procedures globally are also contributing to market growth.

Powered Surgical Instruments Market – The Powered Surgical Instrument Market size is estimated to reach $3.5 billion by 2030, growing at a CAGR of 3.9% during the forecast period 2024-2030; Technological advancements in efficient, precise instruments, rising chronic diseases and trauma cases, growing surgical procedures, and increased healthcare investments drive the powered surgical instrument market.

Operating Room Equipment Market - Operating Room Equipment Market Size is forecast to reach $61000 Million by 2030, at a 4.99% during forecast period 2024-2030. This growth is driven by the increasing number of surgical procedures worldwide, rising investments in healthcare infrastructure, advancements in operating room technologies, and the growing adoption of minimally invasive surgeries.